]>
IRCT138811073200N1 IRCT 2015-04-11 Manoosha-Daru Efficacy of WARTNER anti-wart local drug on genital warts A parallel, self-controlled clinical trial to determine the healing effect of WARTNER in male patients with genital wart 2015-04-21 anticipated 20 Complete https://irct.ir/trial/3241 interventional Randomization: Randomized, Blinding: Not blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment. 3 Genital wart. Intervention 1: Control lesion: no intervention. Intervention 2: Intervention lesion: according to instruction, applicator is placed in sponge section. Then aerocele can is contacted to applicator and sponge is cryoliquid polluted. After waiting for 20 seconds, applicator is placed on the intervention lesion for 20 seconds.
public Alireza Firooz
No. 415, Taleqni Ave
Tehran Iran (Islamic Republic of) 1416613675 +98 88972220 FIROZALI@TUMS.AC.IR Center For Research And Training In Skin Diseases And Leprosy scientific Alireza Firooz
No. 415, Taleqni Ave
Tehran Iran (Islamic Republic of) 1416613765 +98 88972220 FIROZALI@TUMS.AC.IR Center For Research And Training In Skin Diseases And Leprosy Iran (Islamic Republic of) Inclusion criteria: Male sex, >= 18 years old of age, at least 2 genital wart lesion approved by dermatologist, consent to participate and being followed for visits, consent to discontinue the other anti-genital wart drugs Exclusion criteria: diagnosed case of diabetes mellitus, Drug addiction, Other STDs, HIV positive, other immunodeficiency diseases, active skin lesion in genital ares, serious adverse event or intolerance to previous cryotherapy , cold sensitivity history, any tattoo, scar or pigmentation in the field of intervention which could affect the evaluation of the site, Being in the waiting list or participation in another cryotherpy trial at the same time of our study 18 years 139 years Male A63.0 Anogenital (venereal) warts N/A Treatment - Drugs Control lesion: no intervention Intervention lesion: according to instruction, applicator is placed in sponge section. Then aerocele can is contacted to applicator and sponge is cryoliquid polluted. After waiting for 20 seconds, applicator is placed on the intervention lesion for 20 seconds. Intervention and control lesion size. Timepoint: Days 0 and 14. Method of measurement: Caliper and Camera. Clearance of lesion. Timepoint: Day 14. Method of measurement: Observation and photography. Adverse event. Timepoint: 2 weeks after intervention. Method of measurement: Patient information. Lesion recurrence. Timepoint: 6 weeks after intervention. Method of measurement: observation. Manoosha-Daru Approved 2015-04-07 Tehran university of medical sciences, ethics committee TUMS central building, Keshavarz Blvd. Tehran Iran (Islamic Republic of)